Industry News/Legal Issues

U.S. Supreme Court Reviewing AZT Patent Challenge

Published in AIDS Weekly, June 26th, 1995

Barr Laboratories, Inc., Pomona, New York, said that it is pleased with what the company believes is a positive development in its challenge of the Burroughs Wellcome Co.'s patents on zidovudine (AZT).

In March 1995, Barr filed a petition asking the Supreme Court to consider its patent challenge, and the Supreme Court asked the U.S. Justice Department to render its opinion on the case.

"This action by the Supreme Court suggests that the Court is giving our case extended consideration," said Bruce L. Downey, Barr's Chairman, President and CEO. "We believe that this can only be a positive development."

The company petitioned the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-06-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry